Over the years, the adoption of cloud computing in healthcare has increased owing to the rising need to curtail healthcare costs and improve the quality of healthcare. Thus, the stakeholders in t ...
The global biosimilars market in terms of revenue was estimated to be worth $29.4 billion in 2023 and is poised to reach $66.9 billion by 2028, growing at a CAGR of 17.8% from 2023 to 2028. The n ...
The global north american healthcare IT market in terms of revenue was estimated to be worth $193.2 billion in 2022 and is poised to reach $496.7 billion by 2027, growing at a CAGR of 20.8% from ...
The global organ-on-chip market in terms of revenue was estimated to be worth $123,285 thousand in 2024 and is poised to reach $631,073 thousand by 2029, growing at a CAGR of 38.6% from 2024 to 2 ...
The global single use consumables market in terms of revenue was estimated to be worth $2.2 billion in 2022 and is poised to reach $4.7 billion by 2027, growing at a CAGR of 16.6% from 2022 to 20 ...
The global continuous bioprocessing market in terms of revenue was estimated to be worth $218 million in 2023 and is poised to reach $599 million by 2028, growing at a CAGR of 22.4% from 2023 to ...
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this m ...
The global north american healthcare IT market in terms of revenue was estimated to be worth $193.2 billion in 2022 and is poised to reach $496.7 billion by 2027, growing at a CAGR of 20.8% from ...
The global topical drug delivery market in terms of revenue was estimated to be worth $207.4 billion in 2022 and is poised to reach $317.8 billion by 2027, growing at a CAGR of 8.9% from 2022 to ...
The healthcare distribution market is projected to reach USD 1,048.4 billion by 2024, at a CAGR of 6.5%. The prominent players operating in the healthcare distribution market are McKesson Corpora ...
The global antibody therapeutics market in terms of revenue was estimated to be worth $247.3 billion in 2023 and is poised to reach $479.0 billion by 2028, growing at a CAGR of 14.1% from 2023 to ...
The global monoclonal antibody therapeutics market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion by 2029, growing at a CAGR of 14.5% f ...
Latent demand for you, for your prospective client, or your prospective partners